Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122612) titled 'Construction and Feasibility Study of a Home-Based Intelligent Symptom Management Program for Lung Cancer Patients Receiving Combined Drug Therapy Based on Symptom Journey Profiling' on April 15.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Affiliated Hospital of Putian University
Condition:
Primary Lung Cancer
Intervention:
Control group:Routine Follow-up Intervention
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-01
Target Sample Size: Control group:30;Intervention group:30;
Countries of Recruitment:
China
To know more, visit https:/...